FDA
-
-
-
-
-
-
-
Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years for leniolisib
-
-
-
-
-
-
-
Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

